Published in J Cereb Blood Flow Metab on September 30, 2009
Targeting HMGB1 in inflammation. Biochim Biophys Acta (2009) 2.11
Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab (2010) 1.46
Abnormal expression of Toll-like receptor 4 is associated with susceptibility to ethanol-induced gastric mucosal injury in mice. Dig Dis Sci (2013) 1.39
HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab (2010) 1.39
High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke (2010) 1.30
TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion. Mediators Inflamm (2013) 1.18
Toll-like receptors in cerebral ischemic inflammatory injury. J Neuroinflammation (2011) 1.06
Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats. Neuroscience (2011) 1.03
Electroacupuncture pretreatment attenuates cerebral ischemic injury through α7 nicotinic acetylcholine receptor-mediated inhibition of high-mobility group box 1 release in rats. J Neuroinflammation (2012) 1.01
Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats. PLoS One (2014) 0.96
Rosmarinic acid protects against experimental diabetes with cerebral ischemia: relation to inflammation response. J Neuroinflammation (2013) 0.94
Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats. J Cereb Blood Flow Metab (2009) 0.93
HDAC4/5-HMGB1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury. J Cell Mol Med (2013) 0.92
Sodium butyrate protects against severe burn-induced remote acute lung injury in rats. PLoS One (2013) 0.90
Epilepsy and innate immune system: A possible immunogenic predisposition and related therapeutic implications. Hum Vaccin Immunother (2015) 0.88
One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke. Curr Neuropharmacol (2017) 0.84
The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction. Antioxid Redox Signal (2015) 0.82
Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. Cell Death Differ (2015) 0.81
Decreased neuroinflammation correlates to higher vagus nerve activity fluctuations in near-term ovine fetuses: a case for the afferent cholinergic anti-inflammatory pathway? J Neuroinflammation (2016) 0.79
Cerebral ischemic post‑conditioning induces autophagy inhibition and a HMGB1 secretion attenuation feedback loop to protect against ischemia reperfusion injury in an oxygen glucose deprivation cellular model. Mol Med Rep (2016) 0.78
Effects of Etanercept against Transient Cerebral Ischemia in Diabetic Rats. Biomed Res Int (2015) 0.78
Cerebral ischemic damage in diabetes: an inflammatory perspective. J Neuroinflammation (2017) 0.78
Alcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation. Brain Behav Immun (2014) 0.77
High-mobility group box 1 is associated with neurological outcome in patients with post-cardiac arrest syndrome after out-of-hospital cardiac arrest. J Intensive Care (2016) 0.75
Neuroprotective effects of total saponins from Rubus parvifolius L. on cerebral ischemia/reperfusion injury in rats. Neural Regen Res (2012) 0.75
Plasma HMGB-1 and Nucleosome Concentrations in Horses with Colic and Healthy Horses. J Vet Intern Med (2015) 0.75
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature (2002) 19.77
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol (2005) 11.57
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem (2003) 8.34
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol (2007) 8.33
Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A (2003) 7.14
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J (2003) 6.46
Finding nuclear localization signals. EMBO Rep (2000) 6.15
Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis (1989) 5.88
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem (1995) 5.36
High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol (2005) 5.04
Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) (2005) 4.96
The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet (1999) 4.77
The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep (2002) 4.76
HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock (2006) 4.53
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest (2004) 3.89
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem (1994) 3.73
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood (2002) 3.70
High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev (2007) 3.23
Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem (1999) 3.12
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood (2007) 3.09
The cytokine activity of HMGB1. J Leukoc Biol (2005) 3.02
A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem (1973) 2.92
The "cytokine profile": a code for sepsis. Trends Mol Med (2005) 2.89
HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol (2008) 2.80
HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci (2006) 2.68
The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov (2005) 2.57
HMG chromosomal proteins in development and disease. Trends Cell Biol (2006) 2.52
A signature for the HMG-1 box DNA-binding proteins. Bioessays (1993) 2.50
Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery (1999) 2.44
HMGB1: guiding immunity from within. Trends Immunol (2005) 2.42
Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab (2007) 2.31
Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep (2006) 2.29
High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev (2006) 2.26
Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum (2003) 2.26
Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock (2009) 2.26
Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci (2001) 2.15
Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys Res Commun (2006) 2.10
The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci (2008) 2.10
Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J (2007) 1.97
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A (2009) 1.95
Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol (2001) 1.92
Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol (2004) 1.91
High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol (2008) 1.88
Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci U S A (1994) 1.85
Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell (1979) 1.82
Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res (2006) 1.82
Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock (2006) 1.80
High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem (2007) 1.77
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol (2006) 1.73
Regulation of monocyte migration by amphoterin (HMGB1). Blood (2004) 1.69
Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res (2002) 1.63
Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. J Neurosci Res (2008) 1.54
Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit Care (2007) 1.50
Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol (2001) 1.49
30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem (1991) 1.46
Mechanism for specificity by HMG-1 in enhanceosome assembly. Mol Cell Biol (2000) 1.44
Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J Biol Chem (1987) 1.34
Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J Cereb Blood Flow Metab (2008) 1.32
Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine (2003) 1.30
Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J Intern Med (2004) 1.20
HMGB1, a novel inflammatory cytokine. Clin Chim Acta (2006) 1.20
HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine (2002) 1.19
Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience (1998) 1.18
HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expr Patterns (2003) 1.09
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J Neurochem (2006) 1.02
RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease. Curr Mol Med (2007) 0.99
High-mobility group box-1 isoforms as potential therapeutic targets in sepsis. Methods Mol Biol (2007) 0.97
Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Trends Cell Biol (2004) 0.96
Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemia. J Clin Neurosci (2008) 0.96
High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity. J Neurosci Res (2004) 0.96
Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration. J Neurochem (2004) 0.93
Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta. Biochemistry (2001) 0.87
The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes. Int Rev Neurobiol (2007) 0.85
Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. Biochem Biophys Res Commun (2003) 0.85
Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation. Biochem J (2001) 0.84
[Therapeutic effect of anti-nucleokine monoclonal antibody on ischemic brain infarction]. Yakugaku Zasshi (2009) 0.78
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med (2008) 5.15
Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci (2010) 5.12
Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell (2009) 4.71
Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood (2008) 2.96
Hippocampal place cells acquire location-specific responses to the conditioned stimulus during auditory fear conditioning. Neuron (2003) 2.53
Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol (2013) 2.44
Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. Cell (2013) 2.43
Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer. Genes Chromosomes Cancer (2014) 2.24
Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys Res Commun (2006) 2.10
Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A (2007) 2.04
SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase. Cell (2013) 1.97
FTRAC--a robust fluoroscope tracking fiducial. Med Phys (2005) 1.91
The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol Cell (2012) 1.83
Kinematic state estimation and motion planning for stochastic nonholonomic systems using the exponential map. Robotica (2008) 1.74
Molecular and cellular approaches to memory allocation in neural circuits. Science (2009) 1.70
Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett (2008) 1.62
CaMKII binding to GluN2B is critical during memory consolidation. EMBO J (2012) 1.62
Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing. Mol Cell (2013) 1.56
Matching and reconstruction of brachytherapy seeds using the Hungarian algorithm (MARSHAL). Med Phys (2005) 1.49
Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation (2012) 1.40
The impact of orthodontic treatment on the quality of life a systematic review. BMC Oral Health (2014) 1.40
HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab (2010) 1.39
A multiplex RNA-seq strategy to profile poly(A+) RNA: application to analysis of transcription response and 3' end formation. Genomics (2011) 1.37
Putting fear in its place: remapping of hippocampal place cells during fear conditioning. J Neurosci (2004) 1.36
mTOR Inhibition ameliorates cognitive and affective deficits caused by Disc1 knockdown in adult-born dentate granule neurons. Neuron (2013) 1.35
Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J Cereb Blood Flow Metab (2008) 1.32
A powerful and efficient set test for genetic markers that handles confounders. Bioinformatics (2013) 1.32
Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet (2010) 1.31
Quantifying the air pollutants emission reduction during the 2008 Olympic games in Beijing. Environ Sci Technol (2010) 1.30
Gating reaction mechanisms for NMDA receptor channels. J Neurosci (2005) 1.28
MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer (2013) 1.25
LRRC52 (leucine-rich-repeat-containing protein 52), a testis-specific auxiliary subunit of the alkalization-activated Slo3 channel. Proc Natl Acad Sci U S A (2011) 1.22
A study of gibberellin homeostasis and cryptochrome-mediated blue light inhibition of hypocotyl elongation. Plant Physiol (2007) 1.21
Evaluating triggers and enhancers of tau fibrillization. Microsc Res Tech (2005) 1.19
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment. Proc Natl Acad Sci U S A (2012) 1.18
Formation of bilayer bernal graphene: layer-by-layer epitaxy via chemical vapor deposition. Nano Lett (2011) 1.18
Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology (2014) 1.16
Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation. Mol Cell (2012) 1.14
Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. J Neuroinflammation (2013) 1.14
Pathways of tau fibrillization. Biochim Biophys Acta (2005) 1.13
A cis element within flowering locus T mRNA determines its mobility and facilitates trafficking of heterologous viral RNA. J Virol (2009) 1.13
HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. Growth Factors (2008) 1.12
Ultrathin two-dimensional atomic crystals as stable interfacial layer for improvement of lithium metal anode. Nano Lett (2014) 1.12
Adding pyrrolysine to the Escherichia coli genetic code. FEBS Lett (2007) 1.09
Re: Impact of malocclusion on the quality of life of Saudi children. The Angle Orthodontist 2013(6) 1043-1048. Angle Orthod (2014) 1.09
Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis. Lab Invest (2011) 1.08
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses. Arthritis Rheum (2011) 1.08
Long-term outcomes of vaginoplasty with autologous buccal micromucosa. Obstet Gynecol (2014) 1.08
Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am J Pathol (2010) 1.08
Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies. Mol Immunol (2007) 1.07
Annealing-induced interfacial toughening using a molecular nanolayer. Nature (2007) 1.07
Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS One (2012) 1.06
Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One (2010) 1.06
Measuring accurate body parameters of dressed humans with large-scale motion using a Kinect sensor. Sensors (Basel) (2013) 1.06
Isolation of scFvs to in vitro produced extracellular domains of EGFR family members. Cancer Biother Radiopharm (2005) 1.06
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors. Eur J Nucl Med Mol Imaging (2010) 1.05
Versatile pathway-centric approach based on high-throughput sequencing to anticancer drug discovery. Proc Natl Acad Sci U S A (2012) 1.05
An infrared radiation study of the biophysical characteristics of traditional moxibustion. Complement Ther Med (2005) 1.04
Real-time photoacoustic and ultrasound dual-modality imaging system facilitated with graphics processing unit and code parallel optimization. J Biomed Opt (2013) 1.04
General synthesis of (salen)ruthenium(III) complexes via N...N coupling of (salen)ruthenium(VI) nitrides. Inorg Chem (2008) 1.04
Amitriptyline-mediated cognitive enhancement in aged 3×Tg Alzheimer's disease mice is associated with neurogenesis and neurotrophic activity. PLoS One (2011) 1.04
Age-related bone mineral density, bone loss rate, prevalence of osteoporosis, and reference database of women at multiple centers in China. J Clin Densitom (2007) 1.04
Target-responsive "sweet" hydrogel with glucometer readout for portable and quantitative detection of non-glucose targets. J Am Chem Soc (2013) 1.04
Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis. Sci Signal (2013) 1.01
Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB Rep (2009) 1.01
Characteristic and in vitro bioactivity of a microarc-oxidized TiO(2)-based coating after chemical treatment. Acta Biomater (2007) 1.01
A limited access compartment between the pore domain and cytosolic domain of the BK channel. J Neurosci (2006) 1.00
eIF2B promotes eIF5 dissociation from eIF2*GDP to facilitate guanine nucleotide exchange for translation initiation. Genes Dev (2013) 0.99
PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Cardiovasc Res (2011) 0.99
Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells. Mol Cancer (2010) 0.99
Relationships of non-structural carbohydrates accumulation and translocation with yield formation in rice recombinant inbred lines under two nitrogen levels. Physiol Plant (2011) 0.99
MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer. Mol Cell Biochem (2013) 0.99
Controlled synthesis of spinel ZnFe2O4 decorated ZnO heterostructures as peroxidase mimetics for enhanced colorimetric biosensing. Chem Commun (Camb) (2013) 0.99
Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy. Cancer Treat Rev (2012) 0.98
Nasal-type NK/T-cell lymphoma with palatal ulcer as the earliest clinical manifestation: a case report with literature review. Pathol Oncol Res (2009) 0.98
Total tubeless versus standard percutaneous nephrolithotomy: a meta-analysis. J Endourol (2013) 0.96
Photochemical chlorination of graphene. ACS Nano (2011) 0.96
Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage. Ann Neurol (2014) 0.96
Estimation of chlorophyll-a concentration in Turbid Lake using spectral smoothing and derivative analysis. Int J Environ Res Public Health (2013) 0.96
Bioinformatic approaches to metabolic pathways analysis. Methods Mol Biol (2011) 0.96
Laparoscopic fenestration vs open fenestration in patients with congenital hepatic cysts: a meta-analysis. World J Gastroenterol (2011) 0.95
The Ca2+-activated K+ current of human sperm is mediated by Slo3. Elife (2014) 0.95
Impaired auditory information processing during acute migraine: a magnetoencephalography study. Int J Neurosci (2011) 0.95
Spatially filtered magnetoencephalography compared with electrocorticography to identify intrinsically epileptogenic focal cortical dysplasia. Epilepsy Res (2008) 0.95
(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo. Int Immunopharmacol (2005) 0.95
Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats. Acta Pharmacol Sin (2007) 0.94
Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning. Stem Cells (2014) 0.94
Analysis of gene expression profiling in meningioma: deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum. PLoS One (2012) 0.94
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives. Bioorg Med Chem (2007) 0.94
SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development. PLoS One (2012) 0.94